ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Deerfield will fund research at Harvard

by Michael McCoy
March 15, 2019 | APPEARED IN VOLUME 97, ISSUE 11

 

Deerfield Management will put $100 million into biomedical research at Harvard University. The health-care venture firm has launched a new company, Lab1636, that will invest in Harvard R&D projects with the goal of licensing potential new therapeutics to outside companies. The pact is the largest of several Deerfield has formed with universities. Other partners include the University of North Carolina at Chapel Hill and Broad Institute of MIT and Harvard.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment